Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $218.75. The company's market cap stands at 526.85B, with a P/E ratio of 21.10 and a dividend yield of 2.4%.
On 2026-01-19, Johnson & Johnson(JNJ) stock traded between a low of $217.49 and a high of $220.11. Shares are currently priced at $218.75, which is +0.6% above the low and -0.6% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 10.02M, against a daily average of 9.14M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $220.11 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $220.11 at its peak.
JNJ News
Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its fourth-quarter and full-year 2025 results on Jan. 21. The...
Johnson & Johnson (JNJ) is set to report its Q4 earnings on January 21. Analysts expect revenue of about $24.16 billion, up 7.3% year‑over‑year, and earnings of...
Income investors can rely on these stocks. "Set and forget" usually isn't the smartest investing strategy. Things could change with any company, causing you to...
Analyst ratings
56%
of 27 ratingsMore JNJ News
Johnson & Johnson (JNJ) is scheduled to release its fourth-quarter fiscal 2025 results before the market opens on Wednesday, January 21. Analysts expect a sharp...
Earlier this month, ORIC Pharmaceuticals presented its oncology pipeline at the 44th Annual J.P. Morgan Healthcare Conference, highlighting progress on ORIC-944...
Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the June 2027 expiration. One of the key inputs that goes into the price a...
ORIC Pharmaceuticals (ORIC) stock has been in focus after fresh buy ratings from several research firms coincided with encouraging trial updates for its lead on...
Johnson & Johnson recently reported positive topline Phase 3 MajesTEC-9 results showing TECVAYLI monotherapy improved progression-free and overall survival vers...
Johnson & Johnson (NYSE:JNJ) shared topline results from the investigational Phase 3 MajesTEC-9 study of Tecvayli (teclistamab-cqyv) monotherapy for multiple my...
In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $213.83, changing hands for $218.61...